143 Jaksot

  1. Angiosarcoma Essentials

    Julkaistiin: 18.12.2024
  2. The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

    Julkaistiin: 12.12.2024
  3. Women’s Health Frontiers: Breakthroughs from ESMO 2024

    Julkaistiin: 28.11.2024
  4. ESMO Congress Prostate Cancer Highlights

    Julkaistiin: 14.11.2024
  5. How to interpret prognostic models papers in hematology and oncology

    Julkaistiin: 31.10.2024
  6. Stage III Lung Cancer Resecability

    Julkaistiin: 17.10.2024
  7. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

    Julkaistiin: 3.10.2024
  8. Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)

    Julkaistiin: 19.9.2024
  9. Fear of recurrence: one of the major elements in reactivating cancer

    Julkaistiin: 25.7.2024
  10. Immunohistochemistry in oncology

    Julkaistiin: 11.7.2024
  11. Thrombosis and cachexia in cancer: Two partners in crime?

    Julkaistiin: 13.6.2024
  12. From clinical and academic culture in radiation oncology - how to cross the chasm?

    Julkaistiin: 30.5.2024
  13. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Julkaistiin: 16.5.2024
  14. Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Julkaistiin: 30.4.2024
  15. Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Julkaistiin: 18.4.2024
  16. The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    Julkaistiin: 4.4.2024
  17. Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Julkaistiin: 20.3.2024
  18. An inter-specialty cancer training programme curriculum for Europe

    Julkaistiin: 7.3.2024
  19. Communicating the oncological diagnosis: a psycho-oncological perspective

    Julkaistiin: 22.2.2024
  20. ESMO 2023 Highlights on lung cancer

    Julkaistiin: 8.2.2024

1 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site